0 Commentaires
0 Parts
991 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Fil d’actualités
- EXPLORER
-
Pages
-
Groupes
-
Evènements
-
Blogs
-
Offres
-
Emplois
-
Courses
-
Connectez-vous pour aimer, partager et commenter!
-
Tyrosine Kinase Inhibitors Market Analysis, Size, Share, Segments & ForecastExecutive Summary Tyrosine Kinase Inhibitors Market Size and Share Analysis Report The global tyrosine kinase inhibitors market size was valued at USD 63.58 billion in 2024 and is projected to reach USD 100.57 billion by 2032, with a CAGR of 5.90% during the forecast period of 2025 to 2032. With the use of few steps or the combination of several steps, the process of...0 Commentaires 0 Parts 597 Vue 0 Aperçu
-
Tyrosine Kinase Inhibitors Market Share, Size, Emerging Trends and Forecast AnalysisExecutive Summary Tyrosine Kinase Inhibitors Market Size, Share, and Competitive Landscape The global tyrosine kinase inhibitors market size was valued at USD 63.58 billion in 2024 and is projected to reach USD 100.57 billion by 2032, with a CAGR of 5.90% during the forecast period of 2025 to 2032. This Tyrosine Kinase Inhibitors Market report has been generated by...0 Commentaires 0 Parts 573 Vue 0 Aperçu
-
Tyrosine Kinase Inhibitors Market Size, Share and Growth Forecast Report 2032Global Executive Summary Tyrosine Kinase Inhibitors Market: Size, Share, and Forecast Tyrosine Kinase Inhibitors Market Size The global tyrosine kinase inhibitors market size was valued at USD 63.58 billion in 2024 and is projected to reach USD 100.57 billion by 2032, with a CAGR of 5.90% during the forecast period of 2025 to 2032. Tyrosine Kinase Inhibitors Market business report...0 Commentaires 0 Parts 883 Vue 0 Aperçu
-
Tyrosine Kinase Inhibitors Market: Size, Share, Growth, Trends, and Forecast to 2032The Global Tyrosine Kinase Inhibitors Market is poised for steady expansion. Valued at USD 63.58 billion in 2024, the market is projected to reach USD 100.57 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.90% from 2025 to 2032. This article provides a thorough analysis of market dynamics, segmentation, drivers, challenges, and competitive insights, drawing...0 Commentaires 0 Parts 862 Vue 0 Aperçu
-
Brigatinib API Market Growing at 8.1% CAGR Through 2034 GloballyAccording to a new report from Intel Market Research, the global Brigatinib API market was valued at USD 42.5 million in 2025 and is projected to reach USD 89.7 million by 2034, growing at a robust CAGR of 8.1% during the forecast period (2026–2034). This growth is propelled by the increasing global incidence of non-small cell lung cancer, particularly ALK-positive cases among...0 Commentaires 0 Parts 359 Vue 0 Aperçu
-
Global Cabozantinib Drug Market Growing at 7.5% CAGR Through 2034According to a new report from Intel Market Research, the global Cabozantinib Drug market was valued at USD 2.12 billion in 2025 and is projected to reach USD 4.01 billion by 2034, growing at a robust CAGR of 7.5% during the forecast period (2026–2034). This growth is propelled by the escalating global burden of cancer, particularly renal and liver cancers, alongside expanding clinical...0 Commentaires 0 Parts 246 Vue 0 Aperçu
-
Global Multi-target MET TKIs Market Growing at 7.6% CAGR Through 2034According to a new report from Intel Market Research, the global Multi-target MET TKIs market was valued at USD 1.52 billion in 2025 and is projected to reach USD 3.18 billion by 2034, growing at a CAGR of 7.6% during the forecast period (2026–2034). This growth is propelled by the rising global incidence of non-small cell lung cancer and medullary thyroid cancer, precision oncology...0 Commentaires 0 Parts 261 Vue 0 Aperçu
-
TKIs for Breast Cancer Market Growing at 7.3% CAGR Through 2034According to a new report from Intel Market Research, the global TKIs for Breast Cancer market was valued at USD 1.82 billion in 2025 and is projected to reach USD 3.74 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2025–2034). This growth is propelled by the rising global incidence of breast cancer, growing adoption of precision oncology, and increasing regulatory...0 Commentaires 0 Parts 293 Vue 0 Aperçu
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek